Rani Therapeutics Holdings Inc Revenue Growth Rates (RANI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Rani Therapeutics Holdings Inc   (NASDAQ: RANI)
 

RANI's Revenue Growth by Quarter and Year

Rani Therapeutics Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RANI/growth
https://api.csimarket.com/api/v1/companies/RANI/fundamentals
https://api.csimarket.com/api/v1/companies/RANI/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
RANI Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December -
3rd Quarter September 1.71
2nd Quarter June 1.71
1st Quarter March 1.71
FY 5.13

RANIs Annual Revenue
Rani Therapeutics Holdings Inc 's Revenue in the fiscal year 2025 $ 1.63 millions
Rani Therapeutics Holdings Inc 's Revenue in the fiscal year 2024 $ 1.03 millions
Rani Therapeutics Holdings Inc 's Revenue in the fiscal year 2023 $ 0.00 millions
Rani Therapeutics Holdings Inc 's Revenue in the fiscal year 2022 $ 0.00 millions
Rani Therapeutics Holdings Inc 's Revenue in the fiscal year 2021 $ 2.72 millions




RANI Revenue third quarter 2025 Y/Y Growth Comment
Rani Therapeutics Holdings Inc in the third quarter 2025 achieved Revenue of $ 1.71 millions compare to recorded in same quarter a year ago.

According to the results reported in the third quarter 2025, Rani Therapeutics Holdings Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Rani Therapeutics Holdings Inc ' s Revenue no change of 0% ranks overall at the positon no. in the third quarter 2025.


RANI Revenue ( Y/Y Growth %) 2025
 FY 2024 FY 2023 FY 2022
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 905.88 %
FY   -

Financial Statements
Rani Therapeutics Holdings Inc 's third quarter 2025 Revenue $ 1.71 millions RANI's Income Statement
Rani Therapeutics Holdings Inc 's third quarter 2024 Revenue $ 0.00 millions Quarterly RANI's Income Statement


RANI Revenue (Quarter on Quarter Growth %)

 2025
 FY 2024 FY 2023 FY 2022
4th Quarter December -
3rd Quarter September -0.18 %
2nd Quarter June 0 %
1st Quarter March 17.12 %
FY (Year on Year)   -


Back to RANI Growth rate Comparisons >> Back to RANI Growth rate Comparisons >>


Revenue third quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Rani Therapeutics Holdings Inc 's Q/Q Revenue Growth